Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.78% | $13.14M | €450.59B | 80.13% | 76 Outperform | |
| AstraZeneca | 1.57% | $7.40M | $295.20B | 19.89% | 80 Outperform | |
| Novartis AG | 1.54% | $7.29M | CHF230.97B | 25.96% | 80 Outperform | |
| Roche Holding AG | 1.50% | $7.09M | CHF256.31B | 21.75% | 73 Outperform | |
| HSBC Holdings | 1.44% | $6.82M | £202.74B | 35.68% | 80 Outperform | |
| Nestlé SA | 1.38% | $6.54M | CHF204.54B | -0.11% | 71 Outperform | |
| Toyota Motor | 1.09% | $5.14M | ¥43.92T | 22.70% | 80 Outperform | |
| Commonwealth Bank of Australia | 1.07% | $5.07M | AU$290.49B | 22.06% | 64 Neutral | |
| SAP SE | 1.06% | $5.01M | €189.51B | -30.51% | 66 Neutral | |
| Siemens | 1.04% | $4.90M | €167.96B | -4.39% | 74 Outperform |